Pre-clinical investigation of phosphodiesterase 10 (PDE10) inhibitorsas potential therapeutic agents in schizophrenia.

Available drugs to treat schizophrenia are partially effective in controlling symptoms

and have significant side-effect Iiabiltv. We want to explore the potential of PDE1 OA

inhibitors as effective and safe antipsychotic drugs using preclinical models

established in academic supervisor’s laboratory. The compounds will be provided by

Paraza Pharma, who will be better informed about the potential of their compounds in

further testing.

Faculty Supervisor:

Lalit Srivastava

Student:

Partner:

Paraza Pharma Inc

Discipline:

Life Sciences

Sector:

Manufacturing; Professional, scientific and technical services

University:

McGill University

Program:

Accelerate

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects